In this discussion, panelists will share their insights on omnichannel considerations in Medical Affairs.
The discussion will cover:
Medscape Medical Affairs partners with medical affairs teams through a product’s life cycle. We facilitate optimal collaboration between internal teams, physicians, and the broader medical community, connecting you directly with our five million physician members worldwide.
In this episode of the Elevate podcast series, MAPS speaks with experts about tackling the challenges of an expanding world and understanding who is communicating research by measuring Share of Voice.
In 2022, organizations gained ground in patient trust, decentralized clinical trials, virtual tools, and diverse conversations throughout the product development process. So – now what?
The transformation is happening now. Discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization. Using the MAPS Medical Affairs Vision 2030 as our roadmap, experts will discuss the criticality of:
Medical Communications (including scientific writing, and regulatory medical writing) are now increasingly facing newer challenges with developing enhanced content derived from core technical writing. Plain language summaries (PLS) are one such example of enhanced content emerging and steadily gaining importance. Undoubtedly, their contribution to a wider reach from patients to policymakers has gained significance in making informed decisions regarding promoting health benefits from scientific clinical research. Relentless efforts are ongoing by several organizations, bio-pharma companies, medical publishers, and Medical Communications network groups to bring out a standardization of PLS formats. Nonetheless, there has been no broad consensus, although a few guidelines/recommendations are available. In this webinar, we aim to gather insights from expert speakers who will cover practical lived examples of navigating the landscape, cross functional partnership for effective results, challenges that still persist, and future implications addressing the need to establish global guidelines. Perspectives from GPP guidelines, industry/patient experience, and from publishers will be the main focus. A majority of the Medical Affairs professionals, Medical Communications functions (from industry and agencies), individual medical researchers/physicians, and freelance medical writers would benefit from this session. This will be an educative and interactive session with questions and answers to address the audience’s queries.
Medical Affairs is increasingly playing a mission-critical role in bringing novel medicines to patients and working as a value-adding partner with R&D and commercial functions in pharma. In this webinar, a roundtable of experienced Medical Affairs leaders will discuss the opportunities and challenges evolving within their field, as well as the impact it can have on delivering great patient outcomes. The webinar will also explore how, while operating at an asset, above-asset and company-mission level, Medical Affairs can act as an organizational lead across the diverse areas of insight and evidence generation, scientific communication and engagement, patient advocacy and more.
MAPS speaks with Tim Mikelhashvili and winners of his Medical Affairs Innovation Olympics about applications that can match patients with clinical trials and provide real-time input to provide context for clinical decisions.
Medical Affairs teams have emerged as key players not only in advancing the success of their companies, but also in helping to improve patient outcomes. Underpinning this role is their ability to engage customers—especially key external experts—effectively via different channels and activities.
One key to successful KEE engagement is the alignment of tactical execution to a broader corporate/medical strategy. Once the broader strategic imperatives are clear, Medical Affairs (and other departments) can use them to guide their strategic decisions related to KEE engagement and utilization. Clear strategic intent, when coupled with technology allows organizations to make more focused expert selection and utilization decisions spanning the commercialization process of a compound and beyond.
In this webinar, we will discuss how technology has aided Life Sciences leaders as they engage with experts at various stages of the product life cycle from identifying clinical investigators, preparing for a launch and developing focus for a new field medical team(s).
Thecosystems is a stakeholder research subscription service delivered by MMRG.
It takes KOL mapping away from the data geeks; out of the CRM platform; releases it from Excel workbooks and looks at it with a fresh mindset.